Article History
Received: 28 February 2022
Revised: 17 December 2022
Accepted: 30 January 2023
First Online: 8 February 2023
Competing interests
: CLK and AG have a pending PCT/US2022/029842 with the University of Miami, CLK is on the medical advisory board for Interfeen Biologics. All work on this study was performed prior to the MAB position. All other authors have no disclosures.